Alzheimer’s Disease Neuroimaging Initiative

5586 Total Publications

Year	Title	Author	Journal
2016	Cerebrospinal fluid tau, neurogranin, and neurofilament light in Alzheimer’s disease	N. Mattsson, P. S. Insel, S. Palmqvist, E. Portelius, H. Zetterberg, M. Weiner, K. Blennow, O. Hansson and I. Alzheimer's Disease Neuroimaging	Journal EMBO Mol Med;
2016	Plasma tau in Alzheimer disease	N. Mattsson, H. Zetterberg, S. Janelidze, P. S. Insel, U. Andreasson, E. Stomrud, S. Palmqvist, D. Baker, C. A. Tan Hehir, A. Jeromin, D. Hanlon, L. Song, L. M. Shaw, J. Q. Trojanowski, M. W. Weiner, O. Hansson, K. Blennow and A. Investigators	Journal Neurology;
2016	Cerebrospinal fluid tau, neurogranin, and neurofilament light in Alzheimer’s disease	N. Mattsson, P. S. Insel, S. Palmqvist, E. Portelius, H. Zetterberg, M. Weiner, K. Blennow, O. Hansson and I. Alzheimer's Disease Neuroimaging	Journal EMBO Mol Med;
2016	Metabolic connectomics targeting brain pathology in dementia with Lewy bodies	S. P. Caminiti, M. Tettamanti, A. Sala, L. Presotto, S. Iannaccone, S. F. Cappa, G. Magnani, D. Perani and I. Alzheimer's Disease Neuroimaging	Journal J Cereb Blood Flow Metab;
2016	A dynamic tree-based registration could handle possible large deformations among MR brain images	P. Zhang, G. Wu, Y. Gao, P. T. Yap and D. Shen	Journal Comput Med Imaging Graph;
2016	Detection of Alzheimer’s disease at mild cognitive impairment and disease progression using autoantibodies as blood-based biomarkers	C. A. DeMarshall, E. P. Nagele, A. Sarkar, N. K. Acharya, G. Godsey, E. L. Goldwaser, M. Kosciuk, U. Thayasivam, M. Han and B. Belinka	Journal Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring;
2016	Quantitative Neuroimaging Software for Clinical Assessment of Hippocampal Volumes on MR Imaging	J. Ahdidan, C. A. Raji, E. A. DeYoe, J. Mathis, K. O. Noe, J. Rimestad, T. K. Kjeldsen, J. Mosegaard, J. T. Becker and O. Lopez	Journal J Alzheimers Dis;
2016	Manual segmentation of the fornix, fimbria, and alveus on high-resolution 3T MRI: Application via fully-automated mapping of the human memory circuit white and grey matter in healthy and pathological aging	R. S. C. Amaral, M. T. M. Park, G. A. Devenyi, V. Lynn, J. Pipitone, J. Winterburn, S. Chavez, M. Schira, N. J. Lobaugh, A. N. Voineskos, J. C. Pruessner, M. M. Chakravarty and I. Alzheimer's Disease Neuroimaging	Journal Neuroimage;
2016	Amyloid status imputed from a multimodal classifier including structural MRI distinguishes progressors from nonprogressors in a mild Alzheimer's disease clinical trial cohort	D. Tosun, Y. F. Chen, P. Yu, K. L. Sundell, J. Suhy, E. Siemers, A. J. Schwarz, M. W. Weiner and I. Alzheimer's Disease Neuroimaging	Journal Alzheimers Dement;
2016	CSF Aβ1–42 – an excellent but complicated Alzheimer's biomarker – a route to standardisation	J. A. Kuhlmann, A. U., J. Pannee, M. Bjerke, E. Portelius, A. Leinenbach, T. Bittner, M. Korecka, R. G. Jenkins and Vanderstichele	Journal Clinica Chimica Acta;